Global GLP-1 Weight Loss Drug Supply, Demand and Key Producers, 2023-2029

Global GLP-1 Weight Loss Drug Supply, Demand and Key Producers, 2023-2029

The global GLP-1 Weight Loss Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

GLP-1 (Glucagon-Like Peptide-1) weight loss drugs are a class of drugs used to treat obesity and control weight. GLP-1 is a naturally occurring insulin-releasing hormone produced by cells in the small intestine after food ingestion and has multiple physiological effects, including stimulating insulin secretion and inhibiting gastric emptying, thereby slowing the passage of food through the gastrointestinal tract. GLP-1 weight loss drugs simulate the biological activity of GLP-1 and trigger a series of physiological reactions, which help reduce appetite, increase satiety, and reduce calorie intake, thereby helping people lose weight. This class of drugs is often used to treat obesity, especially in obese patients who are at risk for diabetes.

This report studies the global GLP-1 Weight Loss Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for GLP-1 Weight Loss Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Weight Loss Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global GLP-1 Weight Loss Drug total production and demand, 2018-2029, (K Units)

Global GLP-1 Weight Loss Drug total production value, 2018-2029, (USD Million)

Global GLP-1 Weight Loss Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GLP-1 Weight Loss Drug consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: GLP-1 Weight Loss Drug domestic production, consumption, key domestic manufacturers and share

Global GLP-1 Weight Loss Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global GLP-1 Weight Loss Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GLP-1 Weight Loss Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global GLP-1 Weight Loss Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Eli Lilly, Sanofi, BENEMAE, HANSOH PHARMLA, CHIATAI TIANQING, Tonghua Dongbao Pharmaceutical and Huadong Medicine, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Weight Loss Drug market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global GLP-1 Weight Loss Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global GLP-1 Weight Loss Drug Market, Segmentation by Type
Injection
Oral

Global GLP-1 Weight Loss Drug Market, Segmentation by Application
Online Pharmacy
Offline Pharmacy

Companies Profiled:
Novo Nordisk
AstraZeneca
Eli Lilly
Sanofi
BENEMAE
HANSOH PHARMLA
CHIATAI TIANQING
Tonghua Dongbao Pharmaceutical
Huadong Medicine

Key Questions Answered

1. How big is the global GLP-1 Weight Loss Drug market?

2. What is the demand of the global GLP-1 Weight Loss Drug market?

3. What is the year over year growth of the global GLP-1 Weight Loss Drug market?

4. What is the production and production value of the global GLP-1 Weight Loss Drug market?

5. Who are the key producers in the global GLP-1 Weight Loss Drug market?